Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04241146 · ClinicalTrials.gov registry record · NA

Optimal Feeding Tube Placement

A NA study of Enteral Feeding Intolerance, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT04241146 is a NA study of Enteral Feeding Intolerance that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 52 participants, below the 76-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04241146, a NA study of Enteral Feeding Intolerance, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

A randomized controlled trial comparing current standard blind method to CORTRAK enteral access system (CEAS), an FDA approved electromagnetic device to place enteric tubes.

Interventions

  • DEVICE Enteric Tube
  • DEVICE CORTRAK enteral access system

Study Locations (1)

Texas

  • University Hospital - San Antonio

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2018-01-06
Est. Completion 2019-11-21
Phase NA

What the Registry Record Tells You About NCT04241146

The ClinicalTrials.gov registry entry for NCT04241146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 76-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (32% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Enteral Feeding Intolerance appearing as the primary indexed condition, and to 2 interventions - of which Enteric Tube is the first listed.

NCT04241146 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04241146 about?

NCT04241146 is a clinical study titled "Optimal Feeding Tube Placement". A randomized controlled trial comparing current standard blind method to CORTRAK enteral access system (CEAS), an FDA approved electromagnetic device to place enteric tubes.

What is the current status of trial NCT04241146?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2018-01-06. Estimated completion is 2019-11-21.

What conditions does trial NCT04241146 study?

This clinical trial studies the following conditions: Enteral Feeding Intolerance.

What interventions are being tested in trial NCT04241146?

The interventions under investigation include: Enteric Tube (DEVICE), CORTRAK enteral access system (DEVICE).

Who is sponsoring clinical trial NCT04241146?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04241146 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Enteral Feeding Intolerance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.